ELOXX PHARMACEUTICALS INC

Historical 13F Holders

Symbol
ELOX
CUSIP
29014R301
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29014R301 since 12/18/2024, newest first.

Filer % of Class Filed
Samsara BioCapital, L.P. 13G
9.9% 8/14/2026
Event 6/10/2026
Nantahala Capital Management, LLC 13G
9.9% 8/14/2026
Event 6/30/2026
Domicilium Real Estate Fund III LP 13G
20.0% 6/17/2026
Event 6/5/2026
Stonepine Capital Management, LLC 13G
9.9% 6/16/2026
Event 6/9/2026
EcoR1 Capital, LLC 13G
9.9% 6/16/2026
Event 6/9/2026
Invus Global Management, LLC 13G
10.0% 6/15/2026
Event 6/9/2026
Domicilium Real Estate Fund III LP 13G/A Amendment 1
4.9% 6/5/2026
Event 5/27/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 23 2.90 M $40.2 M